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Abstract The study aimed to assess the feasibility and
safety of increasing pulmonary artery band (PAB) diameter
by catheter-based PAB balloon dilation (PABBD). Eight
dilations were performed between October 2006 and
December 2008. Hemoclips were used to fix PABs surgi-
cally in a procedure designed to permit progressive clip
dislodgment in a controlled manner. The PABBD resulted
in gradual band loosening until the desired physiologic
state was achieved. At time of PABBD, the patients had a
mean age of 6 months (range 3–14 months) and a mean
weight of 5 kg (range 2.6–7.3 kg). The median time from
PAB placement until PABBD was 4.5 months (range
1–9 months). The single-balloon technique was used in
seven cases (serial dilations in 5 cases) and the double-
balloon technique in one case. The PABBDs were suc-
cessful for all the patients, who experienced a mean
saturation increase of 75–89% (P = 0.01) (mean increase of
20%), a mean PAB gradient decrease from 69 to 36 mmHg
(P = 0.002) (mean decrease of 49%), and a mean band site
diameter increase from 4.1 to 6.1 mm (P = 0.01) (mean
increase of 45%). The only complication was transient
pulmonary edema in one patient. The PABBD procedure is a
feasible and safe method for increasing pulmonary blood
flow in a staged manner and may eliminate the need for
surgical band removal in some cases.
Keywords Congenital heart disease  Pulmonary artery
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In the modern era, primary complete repair of congenital
heart defects is considered optimal. In certain situations
such as those involving premature infants or complex
defects, such as multiple ventricular septal defects (VSDs)
associated with complex arch and great vessel anatomy
[8, 9], palliative management to reduce pulmonary blood
flow with a pulmonary artery band (PAB) [12, 14] may be a
safer option than complete repair during the neonatal per-
iod. A key consideration with respect to PAB placement,
however, is that the band will become more restrictive as
the patient grows, causing diminished pulmonary blood
flow and progressive cyanosis. This situation has tradi-
tionally required surgical intervention with early repair and
‘‘debanding’’ that may include pulmonary artery patch
plasty or surgical band ‘‘loosening.’’
In the late 1980s and early 1990s, several authors
described various methods of nonsurgical debanding, both
in vitro and in vivo [1, 10, 13, 16, 18]. Technical consid-
erations, however, have led authors to hypothesize that
although cumbersome tools hinder the procedure, the
development of more user-friendly equipment may confer
greater practicality to the process [2]. Interventional
debanding has not been revisited in recent years, but recent
improvements in catheter, wire, and balloon design have
made the prospect of interventional PAB loosening more
feasible.
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This study aimed to review our series of percutaneous
PAB balloon dilations (PABBDs) with a focus on patient
selection and technical aspects.
Methods and Cases
Technique of PAB Placement
The pericardium was opened, and a plane between the
aorta and the pulmonary artery was dissected. The adven-
titial dissection was limited to the space necessary for
placement of a band around the pulmonary artery when
possible. We used polytetrafluoroethylene (PTFE) braided
tape (Bard Peripheral Vascular, Tempe, AZ, USA). Infants
received 2-mm bands, and larger children received wider
bands. A temporary pressure-monitoring catheter was
placed in the distal main pulmonary artery. If a patent
ductus arteriosus was present, it was ligated, and the effect
on the pulmonary artery pressure was noted.
The band was progressively tightened by adding med-
ium ligaclips (Ethicon Endosurgery, LLC, J&J, NJ, USA),
while monitoring the systemic arterial pressure, distal
pulmonary arterial pressure, and peripheral arterial oxygen
saturation. Blood gases also were measured at appropriate
intervals. When the appropriate hemodynamic state was
achieved, the band was secured to the pulmonary artery by
placement of 6–0 Prolene (Ethicon Inc) sutures on opposite
sides of the equator of the proximal pulmonary artery as far
in posterior direction possible (Fig. 1a). No sutures were
placed at the site of band apposition (anteriorly) (Fig. 1c).
This method of clipping and posterior fixation permits the
balloon dilation to cause slippage of the clips over the
PTFE during dilation (Fig. 1b).
A more frequently used method that entails fixing the
band by sutures near the site of band apposition essentially
precludes PABBD because dilation requires breaking the
sutures to enlarge the pulmonary artery diameter. The
consequences are unpredictable and may entail risk of
pulmonary artery rupture.
Technique of PAB Balloon Dilation
Single-Balloon Technique
After appropriate hemodynamic measurements, an angio-
gram was performed with the catheter tip in the right
ventricle or the main pulmonary artery (MPA) proximal to
the PAB. Measurements of the pulmonary valve annulus
(PVA) and the MPA in the lateral projection determined
the maximum balloon size that could be used. Serial dila-
tions, starting with a smaller balloon, allowed for more
controlled band dilation, thus preventing overexpansion
that could lead to pulmonary overcirculation and vessel
rupture (Figs. 2, 3).
The initial balloon selected was 1–2 mm larger than the
angiographic band diameter. Serially larger balloons, not
exceeding the diameter of the PVA or MPA, were selected.
After initial measurements were taken, a guidewire was
placed distally into the pulmonary vasculature of either
branch pulmonary artery using an end-hole catheter such
as a balloon wedge catheter or a 4-Fr angled Glidecatheter
(Terumo Medical Corporation, Somerset, NJ, USA). The
guidewire of choice was dependent on the catheter inter-
nal lumen of the chosen balloon. A 0.035-in. Wholey
Hi-Torque Floppy guidewire (Mallinckrodt Inc., St. Louis,
MO, USA), a 0.014-in. Balance MiddleWeight guide-
wire (Guidant Corporation, Santa Clara, CA, USA), or a
0.035-in. Teflon wire (Cook Medical Inc, Bloomington, IN,
USA) was used. The chosen balloon then was passed over
the wire and inflated to the desired atmospheric pressure
based on the manufacturer’s suggested guidelines.
Noncompliant balloons were used for all the patients
except one to allow for titration of the minimum atmo-
spheric pressure necessary to abolish the waist on the
balloon. In one case (patient 4a in Table 1), only 1 month
after PAB placement in a 2.6-kg premature infant, it was
thought that the use of a compliant balloon might be safer.
This approach achieved adequate dilation and an appro-
priate increase in saturation. However, as the patient con-
tinued to grow and become progressively more cyanotic, a
noncompliant balloon was needed for the second PABBD.
After PAB dilation and loosening, the balloon catheter
was removed, leaving the wire in its distal position, and
arterial saturation was measured. If the desired saturation
was not attained, a larger balloon was selected for further
PAB loosening. This process was repeated until the desired
Fig. 1 Pictorial representation of the position of the pulmonary artery
band (PAB), clips, and sutures. a The sutures are positioned on
opposite sides of the equator of the proximal pulmonary artery, as far
as possible in the posterior direction. b Balloon dilation of he PAB
causes slippage of the clips over the polytetrafluoroethylene (PTFE).
c The more frequently used method pictured earlier entails fixing the
band by sutures anteriorly near the site of band apposition, and thus
precludes balloon dilation
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saturation was achieved, with the upper limit balloon size
not exceeding that of the MPA or PVA. After the final
dilation, the balloon was removed, and a pigtail catheter
was advanced over the wire into the main pulmonary artery
to perform a final angiogram (Figs. 3, 4).
Double-Balloon Technique
For one patient, it was noted that distal PAB migration had
resulted in proximal branch pulmonary artery stenosis.
Therefore, a double-balloon technique was used, with
cannulation of both branch pulmonary arteries using two
end-hole catheters. The balloon sizes used were equal to
the distal branch pulmonary artery measurements beyond
the stenoses. This technique allowed for adequate PAB
dilation without the use of a single balloon too large for
either pulmonary artery branch (Fig. 5).
Procedural success was defined as safe and controlled
serial PABBDs that resulted in the target saturation without
injury to the MPA or PVA. However in case 6 (see the
Results section), the intended result was complete removal
of the PAB and angioplasty of the branch pulmonary
arteries rather than an increase in saturation.
Statistical Methods
All analyses were conducted using Microsoft Office Excel
2003 statistical software (Microsoft Corporation, Redmond,
WA, USA). Means and standard deviations are reported for
Fig. 2 (case 3 in Table 2) The
main pulmonary artery (MPA)
is demonstrated in the lateral
projection before and after
balloon dilation, with an
increase in the diameter of the
pulmonary artery band (PAB)
site from 4.4 to 6.3 mm. Note
the change in the orientation of
the second clip
Fig. 3 (case 4 in Table 2) The
main pulmonary artery (MPA)
is shown in the lateral projection
after serial dilations using a
4-mm balloon followed by a
5-mm balloon, with an increase
in the diameter of the
pulmonary artery band (PAB)
site from 3.1 to 4.2 mm
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all continuous variables. Student’s paired t-test was used for
probability.
Results
Between October 2006 and December 2008, the described
technique of PAB placement was used for all patients who
required a PAB placement regardless of the indication for
banding. Of the 49 patients who received PAB placement, 6
underwent eight PABBDs (2 patients underwent the pro-
cedure twice) (Table 1). At the time of catheterization, the
patients had a mean age of 6 months (range 3–14 months)
and a mean weight of 5 kg (range 2.6–7.3 kg). The median
time from PAB placement was 4.5 months (range
1–9 months).
The two diagnoses that required PAB placement among
our patients were coarctation of the aorta (CoA)/transverse
aortic arch hypoplasia with multiple apical muscular VSDs
(n = 4) and functional single ventricle with unprotected
pulmonary blood flow (n = 2). The single-balloon PABBD
technique was used in seven of the eight cases. Five
patients required serial dilations, and two patients reached
the desired saturation after the first balloon dilation
(Table 2).
The double-balloon PABBD was used for one patient, as
previously described, with intent for both PAB removal
and branch pulmonary artery angioplasty. The balloon
diameters used ranged from 4 to 12 mm. The ratios of the
initial balloon diameter to the minimum diameter at the site
of the PAB using the single-balloon technique ranged from
1.25 to 1.64. Case 6 was an exception because the double
technique was used with balloons sized to perform
both debanding and adequate branch pulmonary artery
angioplasty.











(kg) (months) (kg) (mos)
1 4.8 4 6.3 4 DORV, d-mal GVs, sub-AS, arch hypoplasia/arterial
switch operation & PAB
Glenn at 8 months and a
Rastelli at age of
3 years
2 NA 14 7.3 2 CoA, large apical muscular VSD/arch repair & PAB Residual VSD/rebandeda
3a 2.2 3 3.3 3 Heterotaxy, LV dominant unbalanced AVC, mixed
obstructed TAPVR, common atrium/TAPVR repair
& PAB
Stable saturations, no
other intervention3b 9 7.3 9




8 months later4b 6 3.6 3
5 2.27 3 3.8 3 CoA, large apical muscular VSD/arch repair & PAB CDH/lung
disease/vent
dependentb
Died of CLD 2 months
later
6 2.6 6 6.1 6 CoA, large apical muscular VSD/arch repair & PAB Townes Brock
syndromec
Small residual VSD
a Residual VSD/rebanded: VSD device removed secondary to impaired diastolic function 2 weeks later and PAB replaced
b After repair, could not be weaned off of ventilation and died of CLD (chronic lung disease)
c Townes Brock syndrome (absent radius, webbed neck, absent left kidney)
PABB pulmonary artery band balloon, PAB pulmonary artery band, DORV double outlet right ventricle, d-mal GVs d-malposition of the great
vessels, sub-AS subaortic stenosis, NA not available, CoA coarctation of the aorta, VSD ventricular septal defect, LV left ventricle, AVC
atrioventricular canal defect, TAPVR total anomalous pulmonary venous return CDH congenital diaphragmatic hernia, CLD chronic lung disease
Fig. 4 (case 5 in Table 2) The main pulmonary artery (MPA) is
demonstrated in the lateral projection before and after balloon
dilation. Note that the band site after dilation has approximately the
same diameter as the pulmonary annulus, with poststenotic dilation
distal to it
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The mean initial balloon diameter-to-minimum diameter
ratio among the single balloon technique cases was
1.37 ± 0.17. The ratio of the final balloon diameter to the
initial minimum diameter at the PAB ranged from 1.33 to
1.64 (included in this range are the initial balloon sizes if
only one balloon was used for PABBD) (mean 1.56 ± 0.16).
The ratio of the initial balloon diameter to the MPA or PVA
diameter (whichever was less) ranged from 0.42 to 0.77
(mean 0.57 ± 0.14). The ratio of the final balloon diameter
to the MPA or PVA diameter (whichever was less) was
0.48–0.85 (included in this range are initial balloon sizes if
only one balloon was used for PABBD) (mean 0.64 ± 0.14).
All procedures were successful, as defined in the Methods
and Cases section. Systemic saturation increased from a mean
of 75 ± 11 to 89 ± 9% (P = 0.01), representing a mean
increase of 20 ± 11%. The gradient across the PAB
decreased from a mean of 69 ± 11 mmHg to a mean of
36 ± 15 mmHg (P = 0.002), representing a mean decrease
of 49 ± 17% (procedures 1 and 2 were omitted because
postdilation gradients were not obtained). The band-site
diameter increased from a mean of 4.1 ± 1.5 mm to a mean
of 6.1 ± 2.0 mm (P = 0.01), representing a mean increase of
45 ± 7%. One patient had acute pulmonary edema requiring
mechanical ventilation for 5 days. No other procedure-related
complications occurred. The mean follow-up period was
1.6 years (range 1.8–3.5 years). The details of the follow-up
evaluation are listed in Table 1. Two representative cases are
discussed in more detail in the following sections.
Case 4: PAB Ballooned Twice
A male Down’s syndrome infant of 33 weeks gestation
with transverse aortic arch hypoplasia and multiple mus-
cular VSDs underwent arch repair and PAB at the age of
2 months.
First Balloon Dilation
At 4 months of age (2 months after PAB placement) the
infant boy, weighing 2.6 kg, underwent PABBD secondary
Fig. 5 (case 6 in Table 2) The double-balloon technique for balloon
dilation of the pulmonary artery band (PABBD) is shown in a case of
bilateral branch stenoses. a An angiogram in the caudal angulation
displays severe bilateral branch stenoses due to band distal migration.
b Two 8-mm balloons are inflated simultaneously in both branches.
c Follow-up angiography shows improved caliber of both branch
pulmonary arteries after bilateral balloon dilation
Table 2 Catheterization data
Case PVA MPA Narrow (mm) Gradient (mmHg) Saturations (%) Balloon
(mm) (mm) Before After Before After Before After (mm)
1 9.6 8.2 4.5 7 67 NM 67 76 6–7
2 9.8 12.3 4 5.7 80 NM 70 88 5–6
3a 8.3 8.8 3 4.2 73 38 62a 85a 4
3b 11.3 13.4 4.4 6.3 76 36 60a 78a 7–8
4a 9.3 8.7 3.1 4.2 73 47 87 96 4–5
4b 13 11.9 4.2 6.3 45 21 89a 98a 5–6
5 15.6 16.5 7.3 11 58 10 79 98 12
6 16 16 2.7/2.4b 5.3/6b 75 54/43b 83 90 8 ? 8
a With 100% oxygen
b Left pulmonary artery (LPA)/right pulmonary artery (RPA)
PVA pulmonary valve annulus, MPA main pulmonary artery, NM not measured
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to saturations in the 70’s and suprasystemic right ventric-
ular pressures by echocardiography, suggesting that the
VSDs had become restrictive. The PVA measured 9.3 mm;
the MPA measured 8.7 mm; and the PAB site measured
3.1 mm. Because the VSDs were believed to be restrictive,
it was thought that the patient’s final desired saturation
should be in the upper 90’s. Dilation was performed ini-
tially using a Tyshak miniballoon (B/Braun Medical Inc.
Bethlehem, PA, USA), size 4 mm 9 2 cm, inflated (6 atm)
over an 0.014 Hi-Torque Floppy guidewire, followed by
further ballooning with a Tyshak miniballoon (6 atm), size
5 mm 9 2 cm (Fig. 3). The gradient across the PAB
decreased from 78 to 40 mmHg, and the systemic satura-
tion increased from 75 to 96%. The most narrow area at the
site of the band increased from 3.1 to 4.2 mm.
Second Balloon Dilation
At the age of 6 months (3 months after the PAB), the boy,
weighing 3.6 kg, was referred for further PAB dilation due
to saturations in the 60’s. Echocardiography showed the
development of pulmonary vein stenosis, with a mean gra-
dient of 5–6 mmHg in all four pulmonary veins. The PVA
measured 13 mm; the MPA measured 11.9 mm; and the
PAB site measured 4.2 mm. A Power Xtreme balloon
(Johnson & Johnson, Cordis Corporation, Miami, FL, USA),
size 5 mm 9 2 cm, over a 0.035 in. Teflon wire (20 atm)
was used. The gradient across the PAB decreased from 45 to
35 mmHg, and the saturation increased to 89%.
Further balloon dilation was performed using a Power
Xtreme balloon, size 6 mm 9 2 cm, over the same wire
(24 atm). The gradient further decreased from 35 to
21 mmHg, and the saturation increased from 89 to 98%. The
most narrow area at the site of the band increased from 4.2 to
6.3 mm. During this catheterization, focal pulmonary vein
stenosis at the entrance into the left atrium was confirmed.
At the age of 8 months of age, the boy underwent VSD
closure, pulmonary artery debanding, patch reconstruction,
and pulmonary vein stenosis repair. At this writing, the patient
is doing well, with mild residual pulmonary vein stenosis.
Case 6: Double-Balloon Technique
A double-balloon technique was performed for a male
infant with multiple medical problems including Townes
Brock syndrome, vertebral anomalies, severe scoliosis,
absent right radius, webbed neck, absent left kidney,
transverse arch hypoplasia, tunnel subaortic stenosis, and
an unrestrictive high muscular VSD. He underwent arch
repair and PAB placement at the age of 5 days. When the
boy was 6 months age and weighed 6.1 kg, echocardiog-
raphy showed that the VSD had become smaller, with
moderate branch pulmonary artery stenoses due to distal
PAB migration and encroachment onto the pulmonary
artery bifurcation.
Because the VSD had likely become restrictive and the
PAB was contributing to the development of branch pul-
monary artery stenoses, it was decided that the best course
of action would be complete removal of the band. A
double-balloon technique was therefore used to perform
both angioplasty of the branch pulmonary arteries and
complete debanding. The right pulmonary artery (RPA)
measured 2.7 mm proximally and 6.4 mm distally, and the
left pulmonary artery (LPA) measured 2.4 mm proximally
and 8 mm distally (Fig. 5a). The PVA measured 16 mm,
and the MPA measured 16 mm. The Qp:Qs was 0.75:1.
The right ventricular pressure was systemic, and the PAB
gradient was 75 mmHg into the right pulmonary artery
with a systemic saturation of 83%.
The RPA was cannulated first. With cannulation of the
LPA, pulmonary blood flow was diminished, as evidenced
by decreasing systemic saturations and blood pressure, so no
LPA measurements were performed. Two Powerflex bal-
loons size 8 mm 9 2 cm were placed simultaneously across
the distally migrated PAB and within each branch pulmon-
ary artery over 0.035-in. Teflon wires. Both balloons then
were inflated at the same time to 15 atm (Fig. 5b).
After ballooning, the gradients from the MPA into the
right and left pulmonary arteries were 43 and 54 mmHg,
respectively, with distal mean pressures measuring 25 and
30 mmHg, respectively. Systemic saturations increased
from 83% to 90%, and the Qp:Qs increased to 1.26:1. The
most narrow area of the RPA increased from 2.7 to 5.3 mm
and that of the LPA from 2.4 to 6 mm (Fig. 5c).
The patient remained intubated for 5 days due to acute
pulmonary edema from rapid increase in pulmonary blood
flow. He recovered uneventfully and was discharged from
the hospital 2 weeks later. He was initially managed med-
ically for mild pulmonary overcirculation for 3 months,
after which medications were weaned off due to further
VSD restriction. When the boy was 21 months of age, echo-
cardiography showed further improvement in the branch
pulmonary artery stenosis, with MPA to RPA and LPA
gradients measuring 7 and 13 mmHg, respectively. In ret-
rospect, the VSD was less restrictive than initially suggested
by echocardiography, and serial dilations could have been
performed to avoid pulmonary edema.
Discussion
Effects of Balloon Dilation of PAB on the Pulmonary
Artery
The short-term experience of early surgical debanding
(e.g., hybrid procedure for hypoplastic left heart syndrome)
Pediatr Cardiol (2011) 32:8–16 13
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suggests that most pulmonary arteries are not significantly
scarred or distorted after banding for several months.
Similarly, our procedure involves a ‘‘subacute’’ debanding
(after months), rather than a ‘‘chronic’’ debanding (after
years). Thus, the rationale behind PAB loosening within a
few months of initial placement was based on the specu-
lation that the pulmonary artery may be enlarged at the
band site without disruption of the arterial wall and that by
increasing the diameter of the band through serial balloon
dilations, the vessel may be expanded toward its normal
diameter.
The application of relatively small radial forces allows
for gradual loosening of the band from its initial diameter
by dislodging the surgical clips used to secure it. This
technique permits the use of progressively larger balloons
as required while the balloon waist and both clip movement
and dislodgment are observed to monitor the impact of
balloon dilation.
Technique and Safety of PABBD
Chosen balloon sizes are limited by the angiographic pul-
monary artery diameter and the pulmonary annulus diam-
eter. Initially, a balloon diameter 1 to 2 mm larger than the
angiographic band diameter is used. Balloon diameters are
gradually increased to achieve the desired physiologic
effects. The more recent availability of many small-diam-
eter, low-profile, and compliant angioplasty balloons has
made this feasible. We believe that this conservative,
sequential technique for band enlargement provides a
margin of safety from vessel tears or dissections. Further-
more, the availability of low-profile, 7 9 22-mm Atrium
covered stents (CAST covered stent; Atrium Medical
Corporation, Hudson, NH, USA), which may be mounted
on larger balloons if required, provides an interventional
rescue option for catastrophic vessel rupture. No obvious
pulmonary artery vessel damage has been encountered in
our patients, and we believe that the risk of vessel tear or
dissection is low.
Our study findings show that PABBD can be performed
safely and effectively. The procedure was successful for all
the patients who underwent the procedure with the intent of
increasing baseline saturations without complications. The
procedure also was applied successfully for our patient who
underwent the double-ballooning technique to attain com-
plete debanding due to significant obstruction on the
branch pulmonary arteries. Although this patient subse-
quently experienced a transitory period of pulmonary
edema, the procedure was considered successful because
the significant branch pulmonary artery stenoses were
effectively addressed as intended.
Adjustable PABs
Several reports describe the successful use of adjustable
bands, but notable considerations exist that may preclude
their routine use. Adjustment of PAB using the telemetric
adjustable FloWatch-PAB pneumatic device (EndoArt,
Lausanne, Switzerland) through an external control unit
has been reported. The authors of the report detailed sim-
pler postoperative management and shorter intensive care
unit (ICU) stays. They concluded that the $10,000 cost of
the device was outweighed by a savings in hospital expense
[4, 6, 7, 15]. This device was studied in Europe and cur-
rently is not FDA approved for use in the United States.
Although the reported results showed promise, the authors
thought their study did not prove clinical efficacy of the
FloWatch-PAB compared with standard approaches. Fur-
thermore, placement of this device mandates additional
surgery for eventual removal. This could be an unattractive
option in certain scenarios such as cases of multiple VSDs
that may require only temporary PAB until the VSDs close
or become hemodynamically insignificant. Finally, a sig-
nificant complication has been reported by Venugopal et al.
[17] and Michel-Behnke et al. [11] in which implantation
of the FloWatch-PAB device led to pulmonary artery
transection and pseudoaneurysm formation 6 and 7 weeks
after implantation.
Choudhary et al. [5] described creating an adjustable
PAB using Ethibond suture, a ligaclip, and PTFE with
externalization of the sutures to allow for PAB fine-tuning
in the immediate postoperative period. The sutures then are
internalized before hospital discharge, thus rendering
additional PAB modifications impossible without further
surgery. This technique is potentially useful early after
surgery but is not a long-term solution.
Bonnet et al. [3] advocated the placement of a PAB
made from bioabsorbable materials. Although this is a very
attractive option requiring no further intervention, the
duration of banding is not adjustable. With a fixed mean
banding duration of 5.7 months (range 3–6.5 months), this
system becomes limited when clinicians are dealing with
the dynamic physiology of congenital heart disease of the
young child.
Catheter-Based PAB Dilation
The technique of catheter-based PAB loosening or
debanding was reported as early as 1990. However, tech-
nical considerations limited the procedure. Difficulties with
the manipulation of large balloon catheters (8-Fr) and stiff
balloons led the authors to postulate that whereas the pro-
cedure is hampered by cumbersome tools, the development
of more precise equipment may render the procedure
14 Pediatr Cardiol (2011) 32:8–16
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feasible [2]. Currently, with the availability of softer, more
responsive and kink-resistant catheters as well as improved
more flexible wires and lower-profile more compliant bal-
loons, this technique has become more feasible. However,
concerns still exist about catastrophic acute ruptures, tears,
false aneurysms, and dissections, which may complicate the
use of this technique.
We have performed a PABBD method that allows
minimally invasive dilation or loosening by catheter bal-
loon dilation. We report eight successful procedures in six
cases, with one complication. For all the patients, we were
able to achieve increased pulmonary blood flow when
clinically appropriate, and in four cases, no further inter-
vention for the pulmonary artery band was needed.
Our method for balloon dilation of the PAB was based
on titration of the band diameter to a specific desired sat-
uration. This was accomplished using a balloon diameter
1–2 mm larger than the minimal diameter of the band, not
exceeding the diameter of the PVA or the MPA, whichever
was smaller. For our patients in whom the single-balloon
technique was used, this approach alleviated cyanosis with
the initial chosen balloon in two cases and required up-
sizing once in the remaining five cases. The mean ratio of
the final balloon required for the desired saturation to the
minimal diameter at the PAB was 1.56 ± 0.16. Thus,
perhaps a further refinement of our method for choosing a
balloon would be to opt for a balloon approximately
1.4–1.7 times the minimal diameter. Also, the mean final
balloon diameter was 64 ± 14% of the PVA or MPA
(whichever was least) in our patients, thus allowing for
effective and selective dilation of the PAB while mini-
mizing significant disruption of surrounding structures.
The aforementioned parameters led to an increase in
saturations of 20 ± 11% and a decrease in the gradient
across the PAB of 49 ± 17%, thus ensuring continued
restriction of pulmonary circulation while alleviating
excessive cyanosis. To maintain desired saturations, the
mean PAB dilation required to accommodate somatic
growth was 45 ± 7%, again highlighting the advantage of
progressive percutaneous dilation after one surgical pro-
cedure as an alternative to multiple surgical procedures for
appropriate titration of the band or removal of the band
entirely to avoid excessive cyanosis and thus to tolerate a
degree of pulmonary overcirculation.
Because this study noted only short-term follow-up
evaluation of these patients, long-term effects into adult-
hood are unknown. Also, the small number of procedures
limits our study, thus necessitating further studies and
larger series.
The surgical technique described in this report is our
current standard method of PAB placement on the main
pulmonary artery whether the band is expected to require
further enlargement or not. The surgical and interventional
techniques outlined in this report represent the marriage of
advances in interventional technology with traditional sur-
gical concepts modified to fit current treatment algorithms.
We believe the technique described in this report provides a
safe and effective method for managing the first few months
of life of small infants born with complex cardiac defects
not suitable for safe early primary complete repair.
Continued experience with PABBD in our laboratory
will allow for the long-term assessment of patients who
have undergone the procedure as well as further experience
with more patients, including any possible complications
that may occur. Our additional understanding of these and
other aspects of PABBD will allow for the submission of
further suggestions in the future.
Conclusion
According to the study findings, PABBD is feasible and,
based on this small experience, appears to be a safe method
for augmenting pulmonary blood flow in a controlled
fashion. The PABBD technique may be used as an alter-
native to surgical PAB readjustment. This method can
compensate for somatic growth without having to tolerate
unacceptable cyanosis and without further surgery to adjust
or possibly remove the band.
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